.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Citi
Accenture
Julphar
UBS
Healthtrust
Harvard Business School
Federal Trade Commission
Johnson and Johnson
Novartis

Generated: September 24, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title:Use of oxandrolone in the treatment of burns and other wounds
Abstract: The subject invention provides a method of treating burn-induced weight loss in a burn patient which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The invention also provides a method of treating a wound in a patient suffering from a wound which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The subject invention further provides a method of treating burn-induced weight loss in a burn patient which comprises administering a therapeutically effective amount of an oxandrolone in conjunction with a protein supplement to the patient.
Inventor(s): Fishbein; Don (Westfield, NJ)
Assignee: Savient Pharmaceuticals, Inc. (East Brunswick, NJ)
Filing Date:Mar 12, 2004
Application Number:10/799,264
Claims:1. A method of effecting weight gain after weight loss resulting from burn-induced trauma in a patient which comprises administering to the patient suffering from weight loss resulting from burn-induced trauma 10 mg of oxandrolone per day, up to 100 mg of oxandrolone per day, in conjunction with a protein supplement, for a period of three weeks, so as to effect weight gain in the patient, wherein the weight gained is maintained at eight weeks after discontinuation of the oxandrolone administration.

2. The method according to claim 1 wherein the amount of oxandrolone administered is about 80 mg per day.

3. The method according to claim 1 wherein the amount of oxandrolone administered is about 20 mg per day.

4. The method according to claim 1 wherein the amount of oxandrolone administered is about 10 mg per day.

5. The method according to claim 1 wherein the oxandrolone is administered orally.

6. The method according to claim 1 wherein the oxandrolone is administered topically.

7. The method according to claim 1 wherein the oxandrolone is administered by injection.

8. The method according to claim 1 wherein the oxandrolone is in a solid dosage form.

9. The method according to claim 1 wherein the oxandrolone is in a liquid dosage form.

10. The method according to claim 1 wherein the oxandrolone is in a sustained-release formulation.

11. The method according to claim 1 wherein the oxandrolone is 17.alpha.-methyl-17.beta.-hydroxy-2-oxa-5.alpha.-androstan-3-one.

12. The method according to claim 1 wherein the protein supplement is administered to the patient to achieve a daily protein intake by the patient of 2.0 g/kg/day.

13. The method according to claim 1 wherein the weight gained comprises lean body mass.

14. The method according to claim 1, wherein the oxandrolone is administered orally or by injection.

15. The method according to claim 12, wherein the weight gained per unit time in the patient is double the weight gained by a patient suffering weight loss resulting from burn-induced trauma receiving the protein supplement but not the oxandrolone.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
QuintilesIMS
Baxter
UBS
Queensland Health
Citi
Julphar
Healthtrust
Accenture
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot